JPRN-UMIN000002823已完成2 期
A phase II trial of TS-1 and weelky CDDP combined with hyperthermia as therapy of advanced and relapsed gastric cancer - Combination therapy of TS-1, weekly CDDP, and hyperthermia in advanced and relapsed gastric cancer
Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine0 个研究点目标入组 30 人开始时间: 2009年12月3日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. TS-1 or CDDP is contraindicated drug 2. With active infection or inflammation 3. With severe heart failure 4. Severe complications 5. With large amout of ascites or pleural effusion 6. With bone metastasis 7. With brain metastasis 8. Active gastrointestinal bleeding needing blood infusion 9. With diarrhea 10.Under treatment with antipsychotic tranquilizer 11. With active double cancer 12.Pregnant or nursing women 13.Men who like be pregnant 14.Inappropriate patients for this study judged by the physicians
研究者
相似试验
已完成
1 期
A Phase I/II study of combination of TS-1, CDDP plus PTX in patients with advanced/recurrent gastric cancer (OGSG 0703)JPRN-UMIN000002183OGSG40
招募中
不适用
A Phase II Study of TS-1 + CDDP + Lentinan combination chemotherapy for unresectable or recurrent gastric cancerunresectable or recurrent gastric cancerJPRN-UMIN000010724Jichi Medical University35
进行中（未招募）
2 期
PIT-2Primary lung cancerMediastinal lymph node metastasis, Squamous cell carcinomaJPRN-jRCTs031180403Suzuki Kenji45
已完成
2 期
A phase II trial of induction CDDP plus TS-1 with concurrent radiotherapy followed by surgical resection in patients with resectable stage IIIA-N2 non-small cell lung cancerJPRN-UMIN000018138Gunma University Hospital30
招募中
2 期
A phase II trial of induction CDDP plus TS-1 with concurrent radiotherapy followed by surgical resection in patients with pathologically confirmed stage IIIA-N2 squamous-cell non-small cell lung cancerJPRN-UMIN000012413Advanced Clinical Trial chest surgery Group (ACTG)80